iShares Bitcoin Trust vs NeoGenomics Inc. Common Stock — how do they compare? iShares Bitcoin Trust trades at $45.74 (market cap $66.80B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: iShares Bitcoin Trust is far larger — about 30.8× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 42 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| IBIT | NEO | |
|---|---|---|
Market Cap | $66.80B | $2.17B |
Volume | 40,279,711 | 1,615,943 |
Sector | Crypto-linked | Health |
52-Week High | $65.28 | $19.91 |
52-Week Low | $33.29 | $7.19 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | — | $2.47B |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $47.13, up 0.58% with neutral technical signals. The stock shows bullish moving average momentum but faces resistance at $48. Recent inflows of $196 million on October 1, 2026, highlight renewed institutional interest in BlackRock's ETF offerings, though financial ratios remain undisclosed.
Outlook remains balanced with technical support at $46-$47. Key risks include market volatility and regulatory uncertainty. Analyst sentiment is mixed, with institutional flows suggesting cautious optimism amid broader crypto ETF market resilience.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →